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New Model of a Scaling Dermatosis: Induction of Hyperproliferation in 
Hairless Mice with Eicosa-5,8,11-trienoic acid 
TUAN T. NGUYEN, M .D ., VINCENT A. ZIBOH, PH.D., SHIGEO UEMATSU, M.D., JERRY L. MCCULLOUGH, PH.D., 
AND GERALD WEINSTEIN, M.D. 
Departments of Dermatology and BiochemistlY, University of Miami School of Medicine, Miami, Florida, U.S.A . 
The present studies have demonstrated that topical 
application of a low concentration of eicosa-5,8,1l-tri-
enoic acid (a 20:3,n9 fatty acid previously reported to 
inhibit competitively the activity of the sheep vesicular 
cyclooxygenase) to skin of normal fed hairless mice pro-
duced severe scaly dermatosis which is characterized by 
marked hyperplasia and acanthosis of the epidermal 
layer. The precise mechanism of this induction of scaly 
dermatosis is presently unclear. It is nonetheless inter-
esting that the treatment of skin with similar concentra-
tions of other unsaturated fatty acids produced no visible 
or histologic effects. F urth ermore, endogenous levels of 
arachidonic acid in epidermal phospholipid and triglyc-
eride fractions were shown to increase significantly (p 
< 0.01) in skin treated with the 20:3,n9 fatty acid while 
the endogenous level of PGE2 in the same tissue d e-
creased markedly. This latter observation is consistent 
at least in part, with a previous report from this la bo-
ratory in which the 20 :3,n9 fatty acid inhibited in vitro 
the activity of the sheep vesicular cyclooxygenase (the 
rate limiting enzyme in the transformation of arachi-
donic acid into the prostaglandin endoperoxides) al-
though the incr.ease in arachidonic acid may also reflect 
an increased incorporation of this fatty acid into the 
epidermal lipids by the hyperproliferative tissue. Eval-
uation of the proliferative status of 20:3,n9 fatty acid-
treated skin showed a significant increase (p < 0.01) in 
labeling and mitotic indices. The u se of this potentially 
endogenous fatty acid may be a useful tool for further 
investigations of hyperproliferative skin diseases where 
dietary deficiency of essential fatty acids does not exist. 
The nutritional requirement of mammalian species for cer-
tain essential fatty acids (ETA) was first recognized in young 
rats by Burr and Burr [1,2]. A marked visible abnormality that 
results when rats are maintained on a fat-free or EFA-deficient 
diet over a long period is the development of scaliness of the 
dorsal skin, the feet, and the ta il which later become necrotic. 
This syndrome has been reported in many animal species 
including man [3-7]. T he EFA-deficiency syndrome is also 
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characterized by sharply increased concentrations of one or 
more trienoic acids in the tissues, particularly, the 5,8,1l-eico-
satrienoic acid (20:3,n9). * Interestingly, the increase in this 
20:3,9 fatty acid (ETA) paralleled the decrease in prostaglandin 
E2 (PGE2 ) in the skin of the EFA-deficient animals [6,9). 
Despite this observation, the role of this 20:3,n9 fatty acid 
remained unclear. In a previous study from this laboratory [10] 
to delineate the role of this fatty acid in scaly dermatosis the 
20:3,n9 fatty acid which was isolated from the skin of EF A-
deficient rats competitively inhibited in vitro the oxidation of 
arachidonic acid by sheep vesicular gland cyclooxygenase (a 
rate-limiting enzyme in the transformation of arachidonic acid 
into prostaglandin endoperoxides). In an attempt to ascertain 
whether or not the accumulation of the triene in the skin of 
normal fed animals would inhibit the ability of th e skin pros-
taglandin-synthetizing enzymes to transform endogenous ar-
achidonic acid into prostaglandins (PGs) and whether derma-
tosis can develop, the 20:3,n9 fatty acid was applied topically to 
the skin of normal-fed hairless mice. T he skin was examined 
grossly and histologically for the development of scaly derma-
tosis; endogeno·us skin levels of arachidonic acid and PGE2 were 
assayed; and kinetic parameters of epidermal cell proliferation 
were determined. 
MATERIALS AND METHODS 
Female HRS. J. hairless mice were obtained at approximately 4 
weeks of age. The animals were placed in separate cages a nd were fed 
ad lib with a standard laboratory chow. The 20:3,n9 fatty acid was 
isolated and purified from skin of EFA-defic ient rats as described 
previously [10]. Purity of the fatty acid was confirmed after comparison 
with synthetic ETA gratefully supplied by Drs. U. F . Axen and H . W. 
Smith of Upjohn Co., Kalamazoo. Methyl-CH]-thymidine (specific 
activity 20 fLCi/mmole) was purchased from New England Nuclear. 
Unlabeled linolenic acid, linole ic acid, palmi t ic ac id, and arachidonic 
acid (99% purity) were obta ined from Lipid Organic Research, E lysian, 
Minn . Authentic PGE" was a gift from Dr. U. F. Axen of Upjohn Co., 
Kalamazoo. Organic solvents were redistilled before use. 
Induction of Scaly Dermatosis in Shin of Hairless Mice 
The 20:3,n9 fatty acid was dissolved in a mixtul"e of propylene glycol-
ethanol, 3:7 (v/v) at a concentration of 0.05 M and used for topical 
applications. The fatty ac id was applied gently twice daily to one-half 
of the dorsum of the mouse whereas the other half which served as 
control was treated with vehicle alone. As additional controls, the other 
half of the dorsum was t reated wi th 0.05 M of either palmitic ac id, 
linoleic acid, linolenic acid or arachidonic acid at the same concentra-
tion in other experiments. Generally by the 4th day, the do rsum treated 
with ETA developed scaliness. 
Histological Evaluation, Determination of DNA an.d La.beling Index 
in Epidermal Specimens 
For histological evaluation, 4-mm biopsies were taken from each 
treated area of skin by the 4th day and fixed in Bouin's solu tion. The 
fixed specimens were embedded, sectioned and stained in Ehrlich's 
hematoxylin and eosin. 
To gain information on the incorporation of labeled thymidine in to 
• The notation indicates chain length , number of double bonds and 
position of first double bond, coun ting from the terminal methyl group 
of the fatty acid. 
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DNA a nd the total endogenous level of DNA in the removed layers of 
epidermis 4 days after topical treatment wi th vehicle or ETA, the 
animals were injected fU'st wi th a single pu lse of methyl-e H]-thymidine 
(4 IlCi/g body weight) in traperi toneaily (lP) . Afte r 1 hr, a 4-mm biopsy 
taken from the dorsum of each treated mouse was fixed in Bouin 's 
solution. The specimens were then processed for autoradiography as 
reported previously [11,12). Addit ionaUy, 4-mm biopsies were taken 
from the mice for DNA assay according to Halprin et al [13). Briefly, 
each biopsy was placed in 2 M NaBr and incubated at 37°C for 2 hr to 
separate the epidermis from the dermal layer. The epidermis was 
hydrolyzed in 1 ml of 0.5 NaOH for 2 h1" at 55°C. An aliquot of the 
NaOH hydrolysate was fLltered through a Whatman fil ter paper, the 
residue was washed with a mixture of ethanol:acetic acid (3:1) to 
remove non-incorporated [3H]- thymidine. The fil ter paper was dried 
under suction. The dried fil ter paper containing the labeled DNA was 
transferred into omnifluor-toluene solu tion and coun ted in scint illation 
counter. A portion of the rema ining NaOH hydrolysate (10 Ill) was 
added to 990 III of ethidium bromide in 0.1 M Tris-HCI-O.l M NaCI 
buffer, pH 7.4 and mixed wi th a vortex mixer. The DNA flu orescence 
produced was read in the Turner fluorometer. The amount of DNA in 
the biopsy was determined a fter compaJ'ison wi th a standaJ'd curve 
derived from authentic DNA subjected to the same experimental 
procedUl'e as the skin biopsy. 
D ete rminations of the labeling and mitotic indices were according to 
the procedure previously published by Weinstein [12] and only the 
basal layer was considered in the counting of both mitoses and labeled 
cells . 
Extraction of Tota l Lipids and Sep aration into Classes 
Skin specimens were quickly removed from aJ'eas of the dorsum 
treated wi th vehicle, fatty acid or ETA after 4 days. The specimens 
were minced and homogenized in a mixtUl'e of chloroform:methanol 
(2:1) wi th a Polytron (model PT 10) homogenizer. AJiquots were taken 
for protein assay by the method of Lowry et a l [14] with bovine serum 
used as standard. Tissue debris was removed by fil tration thl'ough glass 
wool and the fi.l t rate evapora ted to dJ'yness in a rotary evaporator. The 
residue of total lipids was redissolved in chloroform:methanol (1:1), 
applied to silica gel coated thin-layer plates and developed in the 
solvent system chloroform:methanol:acetic acid:water (90:8:1:0.8). This 
system sepaJ'ates total lipids into several fractions including pho pho-
lipids, prostaglandins, neutral lipids (triglycerides and s terol esters). 
Estimation of Arachidonic Acid in Phospholipids and Neutral L ipid 
Fractions 
The phospholipid and neutra l lipid fractions were scraped and eluted 
from the plates with chloroform:methanol (1:1) . After dJ'ying, each 
fraction was subj ected to transesterification by refluxing under N2 wi th 
30 ml of a 5% solution of HCI in methanol for 60 min as described 
previously [10). Methyl esters were extracted wi th dichloromethane, 
dJ'ied and then analyzed on an F and M model 402 gas chromatograph 
equiped with a flame ioniza tion detector (FID) system. The glass 
column (6 ft X ';4" ) was packed wi th 15% diethylene glycol succinate 
(DEGS) polyester on ch1"omosorb WA W (S upelco, Bellfonte, Pa) . The 
column temperatUl'e was 190°C and the ni trogen flow was 35 ml/min. 
The methyl esters of aJ'achidonic acid and ETA were identified by 
interna l standards of these 2 fatty acids. Quantitation of both acids was 
by triangulation of the ch1"omatographic peaks and compaJ'ison with 
known peaks of the reference aJ'achidonic acid and the ETA. 
E stimation of PGE l in Prostaglandin Fraction 
The fraction which contained the mixture of prostaglandins was 
scraped and elu ted as described previously. After dJ'ying, the residue 
was re-dissolved in chlorofonn:methanol (1:1), applied to silica gel 
coated TLC plates and developed twice in the solvent system ethyl 
aceta te:acetic acid (99:1) . The portion which conta ined PGE2 was 
transformed into PGB2 with ethanolic-NaOH as reported previously 
[15] and the absorbance determined at 278 nm. Under these condit ions 
the E-prostaglandins or products containing the t.0m'-13-9-keto chro-
mophore by elimina tion of the ll-hydJ·oxy group and isomerization of 
the result ing double bond [16,17]. PGE2 in skin specimens was esti-
mated from a standard CUl've of authentic PGE2 which had undergone 
similar trea tment. 
Statistical Methods 
Sta ndal'd sta tistical methods were used to determine the mean values 
and standard errors of the means. For comparison between the mean 
of the observa tions, S tudent t-test was used. The probabili ty (P) that 
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s tatistical significance was reached was determined at levels between 
0.05 and 0.001. 
RESULTS 
Scaliness of the skin of the hairless mouse was fully evident 
4 days after the application of ETA (0.05 M) twice daily to one-
half of the dorsum whereas the other half which was treated 
with either vehicle or with the other fatty acids (palmitic, 
linoleic, linolenic and arachidonic) at the same concentration 
exhibited no scaly dermatosis. 
Histological evaluations of the vehicle and ET A-treated skin 
specimens are shown in Fig 1 (A and B) photomicrograph. (A ) 
represents the ETA-treated skin which is chru'acterized by 
marked hyperkeratosis and ac:m thosis. Moderate inftl tration of 
inflammatory cells (polymorphonuclear cells) were observed in 
the dermis 4 days after treatment wit h ETA. Approximately, 
there are 5 to 6 layers of epidermal cells on the ETA-induced 
dermatosis when compru'ed to 2 layers of epidermal cells in the 
A 
B 
FIG 1. Histological evalua tion of skin of hairless mice. A , represents 
skin 4 days after treatment with 0.05 M ETA twice da ily. It is chaJ'ac-
terized by maJ'ked hyperkeratosis and acanthosis. B, represents ski n 
after daily tr eatment with vehicle. 
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vehicle-treated skin (E). These effects are similar to those 
previously seen in skin of EFA-deficient rats [9). 
Increased DNA synthesis, Labeling and Mitotic Indices in 
Skin of ETA-treated Mice 
Results in the Table show a significant increase (p < 0.01) in 
the incorporation of methyl-eH}thymidine into epidermal 
DNA of ETA-treated mice. Labeling and mitotic indices were 
also significantly increased (p < 0.01). 
Accumulation of Arachidonic Acid and ETA in Skin Lipid 
Fractions of ETA-treated Mice 
Topical application of ETA to skin of the animals resulted in 
a statistically significant accumulation (p < 0.01) of arachidonic 
acid in the skin after 4 days in both the phospholipid and 
neutral lipid fractions when compared to those animals treated 
with vehicle alone (Fig 2). Examination of the skin specimens 
for other fatty acids particularly revealed a marked elevation of 
ETA in both phospholipid and neutral lipid fractions in the 
dorsal area of the skin treated with ETA. 
Decrease in Skin PGE2 after Topical Treatment with ETA 
Topical treatment of the hairless mice skin with 0.05 M ETA 
twice daily resulted in varying degrees of decrease in skin PGE2 
of all the animals. Results of these studies are shown in Fig 3. 
Collectively, the decrease of PGE2 in the ETA-treated animals 
was statistically significant (p < 0.05) when compared to those 
animals treated with vehicle alone. 
DISCUSSION 
These studies demonstrate that topical application of a low 
concentration (0.05 M) of eicosa-5,8,1l-trienoic acid, a 20:3,n9 
DNA synthesis, labeling and mitotic indices of vehicle and ETA-
treated mice shin" 
Skin Incorporation of Labeling Mitotic 
treatment ["Hl TdR in to DNA index index 
dpm/fLg DNA 
Vehicle 126 ± 32.9" 5 ± 0.51' 1.0 ± 0.1" 
ETA 549 ± 86.2" 28.3 ± 3.7" 4.0 ± 0.4" 
P < 0.01" p < 0.01" p < 0.01" 
" Hairless mice were treated topicaUy either with 0.2 ml of vehicle 
(propylene glycol:ethanol, 3:7, v/v) on one-haH of the dorsum or with 
0.2 ml ETA (0.05 M) in vehicle on the other half twice daily. Animals 
were sacrificed on the 4th day. 
/, Data represents the mean ± SE of duplicate results from 6 animals. 
,. Statistical significance. 
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FIG 2. Effects of ETA-treatment on arachidonic acid and ETA 
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FIG 3. Effect of ETA-treatment on endogenous skin level of PGEz. 
The p-value of the ETA-treated skin is indicated on the figure as p < 
0.05. 
fatty acid (which is not a preCUTsor of prostaglandins) to skin of 
hairless mice produced in a few days a severe scaly dermatosis 
which is characterized by marked hyperplasia and acanthosis 
of the epidermal layer. Because of the extreme sensitivity of 
the skin of these animals to this fatty acid at a very low 
concentration when other fatty acids tested at similar concen-
tration failed to elicit response in the same tissue, we conclude 
that its accumulation in the tissue can initiate undesirable 
biological effects. The precise mechanism of the 20:3,n9 fatty 
acid induction of scaly dermatosis remains to be determined, 
nonetheless, topical application of the fatty acid to the dorsum 
of the hairless mouse resulted in its accumulation as well as 
arachidonic acid in the membrane lipids of the skin. Parallel 
with increases of these fatty acids was the marked decrease in 
PGE2 levels in the skin. Because a previous study from this 
laboratory had demonstrated that 20:3,n9 fatty acid which was 
isolated from the scaly skin of essential fatty acid deficient rats 
inhibits in vitro the oxygenation of arachidonic acid into PGs 
by sheep vesicular gland cyclooxygenase [10], it is reasonable 
to conclude at least in part, that the decrease of endogenous 
PGE2 was due to the inhibition of arachidonic transformation 
into PGs by the topically applied 20:3,n9 fatty acid. Thus, 
altered metabolism of arachidonic acid on the one hand, either 
by dietary deficiency of essential fatty acid [8,9] or by topical 
application of low concentrations of the 20:3,n9 fatty acid can 
result in scaly dermatosis. On the other hand, it is also possible 
that the endogenous accumulation of the abnormaI20:3,n9 fatty 
acid in the skin could result in its fwther metabolism into new 
metabolites such as lipoxygenase products which may directly 
or indi.rectly contribute to the scaly lesions in the skin. In a 
recent report [24] it was demonstrated that eicosapentaenoic 
acid (20:5,n3) can be transformed into leukotriene Cr,. This 
lends support to the possibility that the accumulation of 20:3,n9 
fatty acid in the skin may result in its transformation into 
unique products ofthe lipoxygenase pathway. If this is the case, 
then it might explain the appearance of the inflammatory cells 
at the site of the 20:3,n9-treated skin which at present remains 
unclear. The various leukotrienes so far reported have all been 
shown to be potent chemotactic agents. These possibilities are 
being further investigated. 
Another interesting observation of the applied 20:3,n9 fatty 
acid is the stimulation of the skin proliferative activity in the 
ETA-treated mice (Table). This stimulatory effect is similar to 
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that reported for EFA-deficient rats [11]. Thus, the ETA-
treated skin is a h yp erproliferative tissue when compared to 
skin from normal fed a nimals and thus can serve as a useful 
model for furth er studies of hyperproliferative skin diseases. 
The model is attractive because it employs a substance which 
in vivo can be elevated by desaturation and elongation of oleic 
acid [18] when the metabolism of arachidonic acid is impaired . 
Thus, it differs from other hyperproliferative models which 
employ drastic exogenous agents such as ultraviolet irradiation 
[19] Scotch tape stripping [20] and retinoic acid [21] all of 
which may not be typical of altered metabolic events in the 
skin. 
Because the scaly dermatosis and h yp erplasia can be induced 
without dietary alteration of essential fatty acids the model 
may be helpful in the understanding of certa in forms of human 
scaly d ermatos is where n o evidence of dietary d eficiency of 
essential fatty acid is established, but where its normal metab-
olism may have been a ltered by some other endogenous factor. 
For instance, the scaly d ermatosis associated with psoriasis 
occms d espite the increased accumulation of skin arachidonic 
acid and the increased formation of hydroxy eicosatrienoic acid 
a lipoxygenase product [22]. D ecreased m etabolism of arachi-
donic acid via the cyclooxygenase pathway by the psoriatic 
plaque has also been r eported [23]. Although the natme of the 
inhibitor of arachidonic acid conversion into prostaglandins by 
the psoriatic plaque has not been elucidated, the present studies 
suggest that altered metabolism of skin arachidonic acid may 
be contributory, at least in part, to the development of scaly 
dermatosis in the skin. Thus, the use of metabolites of endog-
enous fatty acids for the disruption of normal meta bolism of 
skin essential fatty acids could serve as useful tool for further 
investigation into in vivo hyperproliferative skin conditions. 
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